What are peptides used for?

Peptides are used across a wide range of medical and research applications. FDA-approved peptide drugs treat conditions including type 2 diabetes and obesity (semaglutide, tirzepatide), growth hormone deficiency (sermorelin, tesamorelin), and hypoactive sexual desire disorder (bremelanotide). Research peptides are being studied for wound healing, neuroprotection, anti-aging, immune modulation, and more, though most lack human clinical trial data.

FDA-approved peptides have undergone rigorous clinical trials demonstrating safety and efficacy for their approved indications. However, the majority of peptides discussed online (BPC-157, TB-500, etc.) have NOT been tested in human clinical trials and their safety profiles are largely unknown. Common side effects of peptide injections in general include injection site reactions, nausea, and headaches. Self-administering unregulated peptides carries significant risks including contamination, incorrect dosing, and unknown long-term effects.

The legality of peptides depends on the specific peptide and jurisdiction. FDA-approved peptides like semaglutide and tirzepatide are legal with a prescription. Many research peptides are sold as 'research chemicals' and are not scheduled as controlled substances, but they cannot legally be marketed for human consumption. In 2024, the FDA placed several popular peptides (including BPC-157 and AOD-9604) on the Category 2 list, prohibiting compounding pharmacies from producing them. State laws vary significantly.

What is the difference between peptides and proteins?

The distinction is primarily one of size. Peptides are short chains of amino acids, typically containing 2 to 50 amino acids linked by peptide bonds. Proteins are larger molecules, generally containing 50 or more amino acids with complex three-dimensional folding structures. Both are made from the same 20 standard amino acids, but proteins have more complex tertiary and quaternary structures that give them different functional properties. Insulin (51 amino acids) sits right at the boundary and is sometimes classified as either.

Do peptides need to be injected?

Most therapeutic peptides are administered via subcutaneous injection because peptides are rapidly broken down by digestive enzymes if taken orally, resulting in very low bioavailability. However, there are exceptions: oral semaglutide (Rybelsus) uses an absorption enhancer (SNAC) to survive the GI tract; some peptides like BPC-157 are studied orally in preclinical models; intranasal delivery is used for peptides like Semax and DSIP; and topical application is used for peptides like GHK-Cu in skincare. The route of administration significantly affects bioavailability and efficacy.

What are GLP-1 peptides?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of peptide drugs that mimic the natural GLP-1 hormone, which regulates blood sugar and appetite. The most well-known are semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). These FDA-approved medications have shown remarkable efficacy for type 2 diabetes management and weight loss, with clinical trials demonstrating 15-22% body weight reduction. They work by stimulating insulin secretion, slowing gastric emptying, and reducing appetite through brain signaling pathways.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. It is one of the most widely discussed research peptides, primarily studied for wound healing and tissue repair. However, it is important to note that nearly all evidence for BPC-157 comes from animal studies (primarily rats) — there are no published randomized controlled human trials. The FDA placed BPC-157 on the Category 2 list in 2024, prohibiting compounding pharmacies from producing it. It is rated Evidence Level C (Preclinical) on PeptideScholar.

How much do peptides cost?

Costs vary enormously depending on the peptide and source. FDA-approved peptides obtained through prescription can cost $500-$1,500+ per month without insurance (e.g., semaglutide at list price). Compounded peptides from licensed pharmacies typically range from $100-$400 per month. Research-grade peptides sold as 'research chemicals' online can be significantly cheaper but come with serious concerns about purity, contamination, and legality. Insurance coverage varies widely, and manufacturer savings programs may reduce costs for FDA-approved options.

Are peptides FDA approved?

Some peptides are FDA approved, but most are not. Over 80 peptide-based drugs have received FDA approval as of 2026, including semaglutide (for diabetes and obesity), tirzepatide (for diabetes and obesity), bremelanotide (for HSDD), sermorelin and tesamorelin (for growth hormone-related conditions), and many others. However, the vast majority of peptides discussed in online wellness communities — including BPC-157, TB-500, CJC-1295, Ipamorelin, and Epithalon — are NOT FDA approved for any indication and remain investigational or research-only compounds.

What are the best peptides for weight loss?

The only peptides with strong clinical evidence (Evidence Level A) for weight loss are the FDA-approved GLP-1 receptor agonists: semaglutide (Wegovy) and tirzepatide (Zepbound). Semaglutide has demonstrated approximately 15% body weight reduction in the STEP trials, while tirzepatide has shown up to 22.5% weight loss in the SURMOUNT trials. Other peptides sometimes discussed for weight loss, such as AOD-9604 and MOTS-c, have limited or preclinical evidence only and are not FDA approved. We strongly recommend focusing on FDA-approved options with proven efficacy and known safety profiles.

What are peptides used for?

Peptides are used across a wide range of medical and research applications. FDA-approved peptide drugs treat conditions including type 2 diabetes and obesity (semaglutide, tirzepatide), growth hormone deficiency (sermorelin, tesamorelin), and hypoactive sexual desire disorder (bremelanotide). Research peptides are being studied for wound healing, neuroprotection, anti-aging, immune modulation, and more, though most lack human clinical trial data.

FDA-approved peptides have undergone rigorous clinical trials demonstrating safety and efficacy for their approved indications. However, the majority of peptides discussed online (BPC-157, TB-500, etc.) have NOT been tested in human clinical trials and their safety profiles are largely unknown. Common side effects of peptide injections in general include injection site reactions, nausea, and headaches. Self-administering unregulated peptides carries significant risks including contamination, incorrect dosing, and unknown long-term effects.

The legality of peptides depends on the specific peptide and jurisdiction. FDA-approved peptides like semaglutide and tirzepatide are legal with a prescription. Many research peptides are sold as 'research chemicals' and are not scheduled as controlled substances, but they cannot legally be marketed for human consumption. In 2024, the FDA placed several popular peptides (including BPC-157 and AOD-9604) on the Category 2 list, prohibiting compounding pharmacies from producing them. State laws vary significantly.

What is the difference between peptides and proteins?

The distinction is primarily one of size. Peptides are short chains of amino acids, typically containing 2 to 50 amino acids linked by peptide bonds. Proteins are larger molecules, generally containing 50 or more amino acids with complex three-dimensional folding structures. Both are made from the same 20 standard amino acids, but proteins have more complex tertiary and quaternary structures that give them different functional properties. Insulin (51 amino acids) sits right at the boundary and is sometimes classified as either.

Do peptides need to be injected?

Most therapeutic peptides are administered via subcutaneous injection because peptides are rapidly broken down by digestive enzymes if taken orally, resulting in very low bioavailability. However, there are exceptions: oral semaglutide (Rybelsus) uses an absorption enhancer (SNAC) to survive the GI tract; some peptides like BPC-157 are studied orally in preclinical models; intranasal delivery is used for peptides like Semax and DSIP; and topical application is used for peptides like GHK-Cu in skincare. The route of administration significantly affects bioavailability and efficacy.

What are GLP-1 peptides?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of peptide drugs that mimic the natural GLP-1 hormone, which regulates blood sugar and appetite. The most well-known are semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). These FDA-approved medications have shown remarkable efficacy for type 2 diabetes management and weight loss, with clinical trials demonstrating 15-22% body weight reduction. They work by stimulating insulin secretion, slowing gastric emptying, and reducing appetite through brain signaling pathways.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. It is one of the most widely discussed research peptides, primarily studied for wound healing and tissue repair. However, it is important to note that nearly all evidence for BPC-157 comes from animal studies (primarily rats) — there are no published randomized controlled human trials. The FDA placed BPC-157 on the Category 2 list in 2024, prohibiting compounding pharmacies from producing it. It is rated Evidence Level C (Preclinical) on PeptideScholar.

How much do peptides cost?

Costs vary enormously depending on the peptide and source. FDA-approved peptides obtained through prescription can cost $500-$1,500+ per month without insurance (e.g., semaglutide at list price). Compounded peptides from licensed pharmacies typically range from $100-$400 per month. Research-grade peptides sold as 'research chemicals' online can be significantly cheaper but come with serious concerns about purity, contamination, and legality. Insurance coverage varies widely, and manufacturer savings programs may reduce costs for FDA-approved options.

Are peptides FDA approved?

Some peptides are FDA approved, but most are not. Over 80 peptide-based drugs have received FDA approval as of 2026, including semaglutide (for diabetes and obesity), tirzepatide (for diabetes and obesity), bremelanotide (for HSDD), sermorelin and tesamorelin (for growth hormone-related conditions), and many others. However, the vast majority of peptides discussed in online wellness communities — including BPC-157, TB-500, CJC-1295, Ipamorelin, and Epithalon — are NOT FDA approved for any indication and remain investigational or research-only compounds.

What are the best peptides for weight loss?

The only peptides with strong clinical evidence (Evidence Level A) for weight loss are the FDA-approved GLP-1 receptor agonists: semaglutide (Wegovy) and tirzepatide (Zepbound). Semaglutide has demonstrated approximately 15% body weight reduction in the STEP trials, while tirzepatide has shown up to 22.5% weight loss in the SURMOUNT trials. Other peptides sometimes discussed for weight loss, such as AOD-9604 and MOTS-c, have limited or preclinical evidence only and are not FDA approved. We strongly recommend focusing on FDA-approved options with proven efficacy and known safety profiles.

What Are Peptides? The Complete Beginner's Guide (2026)

Table of Contents

What Are Peptides?
How Do Peptides Work?
Types of Therapeutic Peptides
FDA-Approved Peptides
Research Peptides
Evidence Levels Explained
Side Effects & Safety
Legal Status
Free Tools
FAQ

What Are Peptides?

Peptides are short chains of amino acids — typically between 2 and 50 — linked together by peptide bonds. They are the building blocks of proteins but are distinguished by their smaller size and simpler structure. While proteins fold into complex three-dimensional shapes and can contain hundreds or thousands of amino acids, peptides are compact molecules that can act as precise biological signals throughout the body.

Your body naturally produces thousands of peptides that serve as hormones, neurotransmitters, and signaling molecules. Insulin, a 51-amino-acid peptide produced by the pancreas, regulates blood sugar. Oxytocin, a 9-amino-acid peptide, plays roles in social bonding and childbirth. Endorphins, the body's natural painkillers, are peptides that bind to opioid receptors. These natural peptides are essential to virtually every physiological process — from immune defense and wound healing to metabolism, cognition, and reproduction.

Peptide therapeutics have become one of the fastest-growing areas of pharmaceutical research and development. Their high specificity, low toxicity profile (relative to small-molecule drugs), and ability to modulate complex biological pathways make them attractive drug candidates. As of 2026, over 80 peptide drugs have received FDA approval, with hundreds more in clinical trials. The global peptide therapeutics market is projected to exceed $80 billion by 2030, driven largely by the success of GLP-1 receptor agonists like semaglutide and tirzepatide for diabetes and obesity.

80+

FDA-Approved Peptide Drugs

As of 2026, including treatments for diabetes, obesity, cancer, osteoporosis, and more

How Do Peptides Work?

Receptor Binding & Signaling

Peptides function primarily by binding to specific receptors on cell surfaces, acting as chemical messengers that trigger intracellular signaling cascades. When a peptide binds to its target receptor — much like a key fitting into a lock — it activates downstream molecular pathways that produce a physiological response. For example, GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating insulin secretion. Growth hormone-releasing peptides (GHRPs) bind to ghrelin receptors in the pituitary gland, triggering growth hormone release.

This receptor specificity is what makes peptides so valuable as therapeutics. Unlike broad-acting small molecules that may interact with many receptor types (causing side effects), peptides tend to bind selectively to their target receptors, resulting in more precise biological effects with potentially fewer off-target interactions.

Routes of Administration

The route of administration significantly impacts a peptide's bioavailability and therapeutic efficacy:

Subcutaneous Injection~100% bioavail.

The most common route. Peptides are injected into the fatty tissue beneath the skin, providing consistent absorption. Used for semaglutide, insulin, and most therapeutic peptides.

Oral~1-2% bioavail.

Challenging due to GI degradation. Oral semaglutide (Rybelsus) uses SNAC, an absorption enhancer, to achieve ~1% bioavailability — enough for therapeutic effect at higher doses.

Intranasal10-50% bioavail.

Used for peptides targeting the CNS. Avoids first-pass liver metabolism. Examples include Semax and DSIP. Bioavailability varies from 10-50% depending on the peptide.

TopicalLocal bioavail.

Used primarily for skin-targeted peptides like GHK-Cu. Limited systemic absorption, which is a feature for cosmetic applications. Common in anti-aging skincare products.

Half-Life & Bioavailability

Most natural peptides have very short half-lives — often measured in minutes — because enzymes called peptidases rapidly break them down in the bloodstream. This is why most peptides need to be injected and why pharmaceutical companies invest heavily in modifications to extend peptide half-lives. Semaglutide, for example, has a half-life of approximately 7 days (enabling weekly dosing) thanks to a fatty acid side chain that binds to albumin, shielding it from enzymatic degradation. In contrast, natural GLP-1 has a half-life of only 1-2 minutes.

Types of Therapeutic Peptides

Therapeutic peptides span a wide range of biological functions. On PeptideScholar, we organize them into 9 research categories based on their primary area of study and therapeutic application.

Healing & Recovery

Peptides researched for wound healing, tissue repair, and recovery from injury.

8 peptides · Top: TeriparatideExplore →

Growth Hormone Secretagogues

Peptides that stimulate the pituitary gland to release growth hormone.

10 peptides · Top: SermorelinExplore →

Weight Loss

Peptides used or studied for weight loss and fat reduction.

11 peptides · Top: SemaglutideExplore →

Sexual Health

Peptides researched for sexual function and desire.

5 peptides · Top: Bremelanotide (PT-141)Explore →

Sleep & Stress

Peptides studied for sleep regulation, anxiolytic effects, and stress response modulation.

5 peptides · Top: DesmopressinExplore →

Cognitive Enhancement

Peptides researched for nootropic and neuroprotective properties.

5 peptides · Top: SemaxExplore →

Anti-Aging & Longevity

Peptides studied for their potential anti-aging effects including telomerase activation.

6 peptides · Top: SS-31 (Elamipretide)Explore →

Immune Support

Peptides involved in immune modulation and antimicrobial defense.

4 peptides · Top: OctreotideExplore →

Anti-Inflammatory

Peptides researched for reducing inflammation through NF-kB and cytokine modulation.

3 peptides · Top: LinaclotideExplore →

FDA-Approved Peptides

These are the only peptides in our database that have been proven safe and effective through rigorous clinical trials and received formal FDA approval for specific medical indications.

Peptide	Brand Names	Approved For	Evidence
Sermorelin	Geref	Diagnosis and treatment of growth hormone deficiency in children	AFDA Approved
Tesamorelin	Egrifta, Egrifta SV	Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy	AFDA Approved
Bremelanotide (PT-141)	Vyleesi	Hypoactive sexual desire disorder (HSDD) in premenopausal women	AFDA Approved
Semaglutide	Ozempic, Wegovy, Rybelsus	Type 2 diabetes mellitus; chronic weight management in adults with obesity or overweight with comorbidities	AFDA Approved
Tirzepatide	Mounjaro, Zepbound	Type 2 diabetes mellitus; chronic weight management in adults with obesity or overweight with comorbidities	AFDA Approved
Liraglutide	Victoza, Saxenda	Type 2 diabetes mellitus (Victoza); chronic weight management in adults with BMI ≥30 or ≥27 with comorbidities (Saxenda)	AFDA Approved
Exenatide	Byetta, Bydureon BCise	Type 2 diabetes mellitus (adjunct to diet and exercise)	AFDA Approved
Dulaglutide	Trulicity	Type 2 diabetes mellitus; cardiovascular risk reduction in adults with T2D and established CV disease or multiple risk factors	AFDA Approved
Teriparatide	Forteo, Bonsity	Osteoporosis in postmenopausal women at high risk of fracture; primary hypogonadal osteoporosis in men; glucocorticoid-induced osteoporosis	AFDA Approved
Octreotide	Sandostatin, Sandostatin LAR Depot	Acromegaly; carcinoid tumors; vasoactive intestinal peptide tumors (VIPomas); control of symptoms related to metastatic neuroendocrine tumors	AFDA Approved
Triptorelin	Trelstar, Triptodur, Decapeptyl	Advanced prostate cancer; central precocious puberty; endometriosis; preoperative treatment of uterine leiomyomata	AFDA Approved
Desmopressin	DDAVP, Nocdurna, Stimate	Central diabetes insipidus; primary nocturnal enuresis; hemophilia A and von Willebrand disease (Type 1); uremic bleeding	AFDA Approved
Setmelanotide	Imcivree	Chronic weight management in adult and pediatric patients aged 6 years and older with obesity due to POMC, PCSK1, or LEPR deficiency, or Bardet-Biedl syndrome	AFDA Approved
Linaclotide	Linzess, Constella	Irritable bowel syndrome with constipation (IBS-C) in adults and children aged 6-17; chronic idiopathic constipation (CIC) in adults	AFDA Approved
Plecanatide	Trulance	Chronic idiopathic constipation (CIC) in adults; irritable bowel syndrome with constipation (IBS-C) in adults	AFDA Approved
Teduglutide	Gattex	Short bowel syndrome in adult and pediatric patients who are dependent on parenteral support	AFDA Approved
Abaloparatide	Tymlos	Osteoporosis in postmenopausal women at high risk of fracture	AFDA Approved
Lanreotide	Somatuline Depot	Unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors; acromegaly	AFDA Approved
Ziconotide	Prialt	Management of severe chronic pain in patients for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatments	AFDA Approved
Vosoritide	Voxzogo	Achondroplasia in children aged 5 years and older with open epiphyses (growth plates)	AFDA Approved
Oxytocin	Pitocin, Syntocinon	Labor induction; control of postpartum uterine bleeding; incomplete or inevitable abortion	AFDA Approved
Gonadorelin (GnRH)	Factrel, Lutrepulse, HRF	Diagnosis of HPG axis function; primary hypothalamic amenorrhea (pulsatile therapy)	AFDA Approved

Research Peptides

The majority of peptides discussed in online communities — including BPC-157, TB-500, CJC-1295, Ipamorelin, MOTS-c, and Epithalon — are not FDA approved for any indication. These are commonly referred to as “research peptides” or “investigational compounds.” While some have promising preclinical data, they lack the rigorous human clinical trials required for regulatory approval.

Level A

FDA Approved

Level B

Human Studies

Level C

Preclinical

Level D

Limited Data

Important Warning About Unregulated Peptides

Research peptides purchased online are unregulated products. Independent testing has repeatedly found issues with contamination, incorrect concentrations, and mislabeled products. The FDA has issued warnings about the risks of self-administering these substances. If you are considering peptide therapy, consult a qualified healthcare provider and use only FDA-approved medications or compounds from licensed pharmacies.

Browse all 57 peptides in our database — each with evidence grades, mechanisms, side effects, and cited research — on our full peptides directory.

Our Evidence Grading System

Every peptide on PeptideScholar is assigned an evidence level from A to D based on the strength and quality of available scientific research. This system helps you quickly distinguish between proven therapeutics and speculative compounds.

AFDA Approved

Level A: Strong Clinical Evidence

FDA-approved therapeutic with multiple randomized controlled trials (RCTs) in humans demonstrating statistically significant efficacy and an established safety profile. These peptides have undergone the full regulatory review process.

Examples: Semaglutide, Tirzepatide, Bremelanotide

BHuman Studies

Level B: Moderate Human Evidence

Supported by published human clinical studies (may include small RCTs, open-label trials, or cohort studies) but either not FDA-approved for the discussed indication or approved in other countries only. Promising but more research needed.

Examples: Semax, Selank, DSIP

CPreclinical

Level C: Preclinical Evidence Only

Evidence comes primarily from animal studies (in vivo) or cell culture experiments (in vitro). No published randomized controlled human trials. Results may be promising but cannot be extrapolated to humans without clinical validation.

Examples: BPC-157, TB-500, MOTS-c

DLimited Data

Level D: Very Limited Data

Minimal published research, unreplicated findings, or largely anecdotal evidence. Scientific support is insufficient to draw meaningful conclusions about efficacy or safety in humans.

Examples: Some newer or obscure peptides

Understanding evidence levels is critical for making informed decisions. A peptide with Level C evidence may have exciting preclinical results, but that does not mean it is safe or effective in humans. Animal studies fail to translate to human outcomes the majority of the time.

Side Effects & Safety

Side effects vary significantly between peptides, but there are some general principles that apply across peptide therapy:

Common Side Effects of Peptide Injections

•Injection site reactions — Redness, swelling, itching, or pain at the injection site. The most common side effect across all injectable peptides.
•Gastrointestinal effects — Nausea, vomiting, diarrhea, and constipation, particularly common with GLP-1 agonists (semaglutide, tirzepatide).
•Headache — Reported across many peptide classes, usually transient and dose-dependent.
•Flushing and dizziness — Common with melanocortin peptides (bremelanotide, Melanotan II).
•Water retention and joint pain — Associated with growth hormone-releasing peptides (GHRPs) due to GH elevation.

Why Human Data Is Limited

For many popular research peptides, comprehensive human safety data simply does not exist. Conducting clinical trials is expensive (typically $50M-$2B per drug) and time-consuming (10-15 years). Many research peptides are naturally occurring molecules that cannot be easily patented, reducing the financial incentive for pharmaceutical companies to fund large-scale trials. This does not mean they are safe or dangerous — it means we do not know.

FDA Category 2 Ban

In 2024, the FDA placed several popular peptides on the Category 2 list under the Federal Food, Drug, and Cosmetic Act. Substances on this list cannot be used by compounding pharmacies to create products for human use. Notable peptides affected include BPC-157, AOD-9604, and several others. This action was taken because these substances lack adequate safety and efficacy data from human clinical trials, and the FDA determined they pose potential risks when used without proper clinical oversight.

WADA Prohibition

The World Anti-Doping Agency (WADA) prohibits the use of most therapeutic and research peptides in competitive sports under section S0 (non-approved substances) and S2 (peptide hormones, growth factors, and related substances). Athletes should be aware that the use of virtually any non-prescribed peptide could result in a doping violation, regardless of whether it is a controlled substance in their jurisdiction.

Legal Status

The legal landscape for peptides in the United States is complex and varies by peptide type, intended use, and state jurisdiction. Here is a brief overview:

FDA-Approved Peptides

Legal with a valid prescription from a licensed healthcare provider. Manufactured by FDA-regulated pharmaceutical companies under strict quality controls.

Compounded Peptides

Some peptides not on the Category 2 list may still be compounded by licensed 503A/503B pharmacies with a prescription. Rules vary significantly by state pharmacy board.

Research Chemicals

Peptides sold 'for research purposes only' exist in a legal gray area. Not scheduled as controlled substances but cannot legally be marketed for human consumption. Buyer assumes all risk.

For a comprehensive, state-by-state breakdown of peptide legality, consult our full 50-state legal guide or use the Legal Status Checker tool to look up a specific peptide in your state.

Free Peptide Tools

We built a growing toolkit of free peptide calculators, checkers, and planners to help you navigate the peptide landscape. No signup required.

Peptide Finder

Answer 4 questions to get personalized peptide research recommendations based on your interests.

Reconstitution Calculator

Calculate reconstitution volumes and syringe units for any peptide vial instantly.

Legal Status Checker

Check peptide legality in your state. FDA status, compounding rules, and restrictions.

Titration Planner

Map escalation schedules, dose steps, and weekly protocol changes for GLP-1 and peptide use cases.

Frequently Asked Questions About Peptides

Join the Netherlands peptide waitlist

We will notify you when Netherlands-specific legal guides, provider flows, and tracker support are ready.

No spam. Unsubscribe anytime.

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.